Sunshine Biopharma director Andrew Keller declines to seek board reelection
SBFM•Director will not stand for reelection
Sunshine Biopharma director Andrew Keller will not seek re-election when his term ends at the next annual shareholder meeting.
Keller notified the company of his decision on Aug. 25, 2026.
